Cargando…

1069. Loss to follow-up does not impact SVR for HCV infection

BACKGROUND: Recent advances in hepatitis C treatment using direct acting antiviral (DAA) agents can lead to sustained virologic response (SVR) in almost all treated subjects. These data along with the availability of generic DAAs have generated optimism to eliminate HCV infection globally. However,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kottilil, Sita K, Kamat, Mrunal, Gupte, Amit, Shah, Samir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777501/ http://dx.doi.org/10.1093/ofid/ofaa439.1255

Ejemplares similares

1060. Evaluation of ALT at Sustained Virologic Response (SVR) in Patients with Treated Hepatitis C Virus (HCV) Infection
por: Theppote, Amanda, et al.
Publicado: (2020)

Effect of HIV infection-related factors on SVR rate in HCV treatment in HIV-infected patients
por: Kravchenko, Alexey, et al.
Publicado: (2014)

Peripheral PD-1(+) T Cells Co-expressing Inhibitory Receptors Predict SVR With Ultra Short Duration DAA Therapy in HCV Infection
por: Romani, Sara, et al.
Publicado: (2019)

1979. Time to Viral Suppression Does Not Impact SVR in Patients Treated With Glecaprevir/Pibrentasvir for 8 Weeks
por: Sarrazin, Christoph, et al.
Publicado: (2018)

1069. Predictive Factors for Metastatic Infection in Patients With Bacteremia Caused by Staphylococcus aureus
por: Shimizu, Akihiro, et al.
Publicado: (2018)

1069. Implementation and Results of a Health-System Antimicrobial Stewardship (AMS) Program
por: Boldt, Dayla, et al.
Publicado: (2019)

Characteristics and Survival Outcomes of Hepatocellular Carcinoma Developed after HCV SVR
por: Yeh, Ming-Lun, et al.
Publicado: (2021)

P1069: RETROSPECTIVE COMPARISON OF PATIENT OUTCOMES ON PACRITINIB VERSUS RUXOLITINIB IN PATIENTS WITH MYELOFIBROSIS AND THROMBOCYTOPENIA
por: Harrison, C., et al.
Publicado: (2022)

2896. Reduction in Liver-related Mortality Among HCV Infected Persons Is Driven by Attainment of SVR Independent of the Regimen Used: Results from the ERCHIVES Cohort
por: Butt, Adeel A, et al.
Publicado: (2019)

1069 Long-term effect of a Birth Vaccination Promotion Strategy
por: Gagneur, Arnaud, et al.
Publicado: (2014)

1062. HCV GET-UP: A Group Evaluation and Treatment Uptake Intervention Improves HCV Linkage to Care for PWID
por: Norton, Brianna L, et al.
Publicado: (2020)

Quadruple Therapy Offers High SVR Rates in Patients with HCV Genotype 4 with Previous Treatment Failure
por: Abo-amer, Yousry Esam-Eldin, et al.
Publicado: (2020)

Prevalence and predictors of abnormal alanine aminotransferase in patients with HCV who have achieved SVR
por: Chadha, Nikita, et al.
Publicado: (2022)

Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR
por: Vigón, Lorena, et al.
Publicado: (2019)

Concordance of SVR12, SVR24 and SVR durability in Taiwanese chronic hepatitis C patients with direct-acting antivirals
por: Lin, Chuan-Pin, et al.
Publicado: (2021)

Increasing numbers of acute hepatitis C infections in HIV-infected MSM and high reinfection rates following SVR
por: Stellbrink, HJ, et al.
Publicado: (2010)

The four orchestral suites, BWV 1066-1069 /
por: Bach, Johann Sebastian, 1685-1750
Publicado: (2000)

Genetic characterization of novel class 1 Integrons In0, In1069 and In1287 to In1290, and the inference of In1069-associated integron evolution in Enterobacteriaceae
por: Wang, Dongguo, et al.
Publicado: (2017)

Hepatitis C treatment outcomes for Australian First Nations Peoples: equivalent SVR rate but higher rates of loss to follow-up
por: Clark, Paul J., et al.
Publicado: (2022)

Impact of Insurance and Treatment Regimens on HCV Outcome: Long-term Follow-up Study
por: Mukka, Mallikarjuna, et al.
Publicado: (2017)

1393. Loss to Follow-up Rate in the Treatment of Latent Tuberculosis by Region of Origin
por: Yoshii, Hikari, et al.
Publicado: (2021)

859. Suboptimal Uptake, Retention, and Adherence of Daily Oral PrEP Among People with OUD Receiving HCV Treatment
por: Brokus, Christopher J, et al.
Publicado: (2021)

Effects of Achieving SVR on Clinical Characteristics and Surgical Outcomes in Patients Who Developed Early-Stage HCV-Related Hepatocellular Carcinoma and Received Curative Resection: Preoperative versus Postoperative SVR
por: Hsu, Po-Yao, et al.
Publicado: (2022)

4 Ouvertüren, BWV 1066-1069 Suites ; Ouvertüre BWV 1070 /
por: Bach, Johann Sebastian, 1685-1750
Publicado: (1986)

SVR Rates of HCV-infected population under PEG-IFN-α/R treatment in Northwest China
por: Li, Yanhua, et al.
Publicado: (2017)

HCV Integrated Care: A Randomized Trial to Increase Treatment Initiation and SVR with Direct Acting Antivirals
por: Groessl, Erik J., et al.
Publicado: (2017)

Dynamics of APRI and FIB-4 in HCV cirrhotic patients who achieved SVR after DAA therapy
por: Leuştean, Anca, et al.
Publicado: (2021)

Distribution of pimonidazole and RSU 1069 in tumour and normal tissues.
por: Cobb, L. M., et al.
Publicado: (1990)

Studies of the in vivo and in vitro cytotoxicity of the drug RSU-1069.
por: Hill, R. P., et al.
Publicado: (1986)

P1069: GONADAL FUNCTION AND FERTILITY PRESERVATION IN PEDIATRIC PATIENTS WITH HODGKIN LYMPHOMA TREATED ACCORDING TO THE EURONET-PHL-C2 PROTOCOL: THE FERTILITY ADD-ON STUDY
por: Drechsel, Katja, et al.
Publicado: (2023)

Influence of Genetic Variants on Disease Regression and Outcomes in HCV-Related Advanced Chronic Liver Disease after SVR
por: Semmler, Georg, et al.
Publicado: (2021)

Dynamic Changes in Non-Invasive Markers of Liver Fibrosis Are Predictors of Liver Events after SVR in HCV Patients
por: Fernández-Alvarez, Paula, et al.
Publicado: (2023)

1069. Pharmacological preconditioning with vitamin c attenuates intestinal injury via the induction of heme oxygenase-1 after hemorrhagic shock in rats
por: Zhao, B, et al.
Publicado: (2014)

1031. Mobility and Structural Barriers Contribute to Loss to Follow up from HIV Care in Rural South Africa
por: Hannaford, Alisse, et al.
Publicado: (2020)

Mechanisims of asthma and allergic disease – 1069. Down regulation of IL-13 secretion in mononuclear cells by a beta-adrenergic blocker
por: Hajighasemi, Fatemeh
Publicado: (2013)

932. Creating a Statewide HCV Treatment Cascade for HIV/HCV Co-Infected Persons Using a Partnership with DPH
por: Wegener, Maximilian D, et al.
Publicado: (2020)

Su1069: THE INCIDENCE OF GASTROINTESTINAL SYMPTOMS IN 567 SARS-COV-2 IINFECTED PATIENTS DURING THE SURGE DUE TO DELTA VARIANT, AND THE IMPACT ON THE HEALTHCARE SYSTEM.
por: Hemaidan, Ammar, et al.
Publicado: (2022)

957. Efficacy of Using Disease Intervention Specialists (DIS) to Re-engage Out of Care HIV/HCV Co-Infected Persons into HCV Treatment
por: Wegener, Maximilian D, et al.
Publicado: (2020)

1057. CpG-adjuvanted Hepatitis B vaccination improves seroprotection rates in Veterans with HIV
por: Deming, Meagan, et al.
Publicado: (2020)

933. Cured vs. Not Yet Treated: Population Differences for HIV/HCV Co-infected Patients Navigating the HCV Care Cascade in 11 Connecticut Clinics
por: Brooks, Ralph P, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jn6g290pnac8cv71c9m3199fkm